This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study of KK2269 in Adult Participants With Solid Tumors | MicrobiomeTrials
← Back to trials NCT06266299
A Study of KK2269 in Adult Participants With Solid Tumors Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-01-18Est. Completion: 2029-03
Enrollment target: 83 participantsLocations Mayo Clinic Arizona, Scottsdale, Arizona, United States City Of Hope National Medical Center, Duarte, California, United States Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States Mayo Clinic Jacksonville, Jacksonville, Florida, United States Washington University, St Louis, Missouri, United States The University of Texas Southwestern Medical Center, Dallas, Texas, United States University of Washington, Seattle, Washington, United States Aichi Cancer Center, Nagoya, Aichi-ken, Japan Fujita Health University Hospital, Toyoake, Aichi-ken, Japan National Cancer Center Hospital East, Kashiwa, Chiba, Japan National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan Kurume University Hospital, Kurume, Fukuoka, Japan Kobe Minimally Invasive Cancer Center, Kobe, Hyōgo, Japan Kanagawa Cancer Center, Yokohama, Kanagawa, Japan Kansai Medical University Hospital, Hirakata, Osaka, Japan Kindai University Hospital, Sakai, Osaka, Japan Other microbiome trials you might be interested in Recurrent Breast Carcinoma Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7
This randomized phase II trial studies how well tamoxifen citrate works compared with z-endoxifen hydrochloride in treat…
Mobile, United States Est. completion Nov 6, 2020
Non-small Cell Lung Cancer
NHO Kinki-Chuo Chest Medical Center, Sakai, Osaka, Japan
Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka, Japan
Saitama Prefectural Cancer Center, Shinden, Saitama, Japan
Shizuoka Cancer Center, Nagaizumi-chō, Shizuoka, Japan
Tochigi Cancer Center, Utsunomiya, Tochigi, Japan
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyō-Ku, Tokyo, Japan
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
Cancer Institute Hospital of JFCR, Koto-Ku, Tokyo, Japan
National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
Hiroshima University Hospital, Hiroshima, Japan
Kumamoto University Hospital, Kumamoto, Japan
Nagasaki University Hospital, Nagasaki, Japan
Niigata Cancer Center Hospital, Niigata, Japan
Okayama University Hospital, Okayama, Japan
Osaka International Cancer Institute, Osaka, Japan
Toyama University Hospital, Toyama, Japan This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participa…
Bakersfield, United States Est. completion Jan 24, 2028
Malignant Pleural Mesothelioma, Advanced
This Phase 1b/2, open-label, multicenter, single-arm study evaluates the safety and efficacy of ivonescimab in combinati…
Shanghai, China Est. completion Nov 30, 2028